Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

1,121

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

April 30, 2018

Conditions
Migraine Disorders
Interventions
BIOLOGICAL

ALD403 (Eptinezumab)

BIOLOGICAL

Placebo

Trial Locations (144)

1033

Research Site, Budapest

1083

Research Site, Budapest

1090

Research Site, Brussels

1145

Research Site, Budapest

2600

Research Site, Glostrup Municipality

4000

Research Site, Liège

7623

Research Site, Pécs

8800

Research Site, Viborg

10016

Research Site, New York

10019

Research Site, New York

10117

Research Site, Berlin

11229

Research Site, Brooklyn

11803

Research Site, Plainview

14226

Research Site, Amherst

14609

Research Site, Rochester

15478

Research Site, Smithfield

15683

Research Site, Scottdale

18200

Research Site, Prague

19002

Research Site, Guadalajara

20132

Research Site, Milan

20133

Research Site, Milan

20246

Research Site, Hamburg

20603

Research Site, Waldorf

21005

Research Site, Vinnytsia

23294

Research Site, Richmond

25198

Research Site, Lleida

27100

Research Site, Pavia

27262

Research Site, High Point

27705

Research Site, Durham

28046

Research Site, Madrid

28050

Research Site, Madrid

28222

Research Site, Madrid

28223

Research Site, Madrid

29464

Research Site, Mt. Pleasant

30030

Research Site, Decatur

30328

Research Site, Atlanta

30342

Research Site, Atlanta

31008

Research Site, Navarrés

32256

Research Site, Jacksonville

32806

Research Site, Orlando

33155

Research Site, Miami

33407

Research Site, West Palm Beach

33606

Research Site, Tampa

33880

Research Site, Winter Haven

35235

Research Site, Birmingham

37203

Research Site, Nashville

37404

Research Site, Chattanooga

37421

Research Site, Chattanooga

38119

Research Site, Memphis

39008

Research Site, Santander

39232

Research Site, Flowood

41013

Research Site, Seville

44718

Research Site, Canton

45122

Research Site, Nordheim

45432

Research Site, Dayton

46011

Research Site, Anderson

46026

Research Site, Valencia

47005

Research Site, Valladolid

48104

Research Site, Ann Arbor

49027

Research Site, Dnipropetrovsk

49045

Research Site, Dnipro

50309

Research Site, Des Moines

55402

Research Site, Minneapolis

60020

Research Site, Ancona

60607

Research Site, Chicago

60642

Research Site, Chicago

61068

Research Site, Kharkiv

61103

Research Site, Kharkiv

61500

Research Site, Brno

61820

Research Site, Champaign

63141

Research Site, St Louis

63303

Research Site, City of Saint Peters

65014

Research Site, Odesa

65810

Research Site, Springfield

66208

Research Site, Prairie Village

66212

Research Site, Overland Park

67207

Research Site, Wichita

69065

Research Site, Zaporizhzhya

70072

Research Site, Marrero

72211

Research Site, Little Rock

73116

Research Site, Oklahoma City

75214

Research Site, Dallas

76008

Research Site, Ivano-Frankivsk

76180

Research Site, North Richland Hills

77058

Research Site, Houston

77081

Research Site, Houston

78258

Research Site, San Antonio

79010

Research Site, Lviv

80131

Research Site, Napoli

80918

Research Site, Colorado Springs

82008

Research Site, Unterhaching

84109

Research Site, Salt Lake City

84123

Research Site, Salt Lake City

85032

Research Site, Phoenix

87102

Research Site, Albuquerque

89113

Research Site, Las Vegas

90404

Research Site, Santa Monica

90502

Research Site, Torrance

91054

Research Site, Erlangen

92011

Research Site, Carlsbad

92056

Research Site, Oceanside

92108

Research Site, San Diego

92374

Research Site, Redlands

92868

Research Site, Orange

93030

Research Site, Oxnard

94304

Research Site, Palo Alto

97404

Research Site, Banská Bystrica

98007

Research Site, Bellevue

99202

Research Site, Spokane

121467

Research Site, Moscow

150030

Research Site, Yaroslavl

191144

Research Site, Saint Petersburg

194044

Research Site, Saint Petersburg

194223

Research Site, Saint Petersburg

420064

Research Site, Kazan'

620102

Research Site, Yekaterinburg

630051

Research Site, Novosibirsk

630054

Research Site, Novosibirsk

660037

Research Site, Krasnoyarsk

06320

Research Site, New London

02135

Research Site, Boston

02740

Research Site, North Attleboro

02472

Research Site, Watertown

03756

Research Site, Lebanon

08540

Research Site, Princeton

565 01

Research Site, Choceň

100 34

Research Site, Prague

0112

Research Site, Tbilisi

0160

Research Site, Tbilisi

0179

Research Site, Tbilisi

0186

Research Site, Tbilisi

00163

Research Site, Roma

026 01

Research Site, Dolný Kubín

01841

Research Site, Dubnica nad Váhom

053 42

Research Site, Krompachy

03010

Research Site, Alicante

08035

Research Site, Barcelona

08221

Research Site, Terrassa

G51 4TF

Research Site, Glasgow

IV2 3UJ

Research Site, Inverness

SE5 9PL

Research Site, London

NE1 4LP

Research Site, Newcastle

M8 8HD

Research Site, Salford

ST4 7LN

Research Site, Stoke-on-Trent

Sponsors
All Listed Sponsors
lead

Alder Biopharmaceuticals, Inc.

INDUSTRY

NCT02974153 - Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine | Biotech Hunter | Biotech Hunter